Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Labopin

Showing results (231-240 of 443) with videos related to

Pageof 45
Sort By:
Bone Marrow Transplantation|May 11, 2020
Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remissionRoni Shouval, Myriam Labopin, David Bomze, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantationArnon Nagler, Vanderson Rocha, Myriam Labopin, et al.
Bone Marrow Transplantation|September 29, 2019
Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working PartyAbdul Hamid Bazarbachi, Rama Al Hamed, Myriam Labopin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2020
Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent YearsAli Bazarbachi, Christoph Schmid, Myriam Labopin, et al.
Bone Marrow Transplantation|October 6, 2020
Comparable outcomes of haploidentical transplant with TBF conditioning versus matched unrelated donor with fludarabine/busulfan conditioning for acute myeloid leukemiaAli Bazarbachi, Myriam Labopin, Didier Blaise, et al.
American Journal of Hematology|July 31, 2018
Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remissionFrancesca Lorentino, Myriam Labopin, Massimo Bernardi, et al.
Leukemia|July 28, 2018
European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantationNicole Engel, Alicia Rovo, Manuela Badoglio, et al.
Blood|June 12, 2004
Hematopoietic stem cell transplantation for de novo acute megakaryocytic leukemia in first complete remission: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)Laurent Garderet, Myriam Labopin, Norbert-Claude Gorin, et al.
American Journal of Hematology|March 26, 2018
Cyclophosphamide versus etoposide in combination with total body irradiation as conditioning regimen for adult patients with Ph-negative acute lymphoblastic leukemia undergoing allogeneic stem cell transplant: On behalf of the ALWP of the European Society for Blood and Marrow TransplantationAnna Czyz, Myriam Labopin, Sebastian Giebel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 1, 2014
Autologous hematopoietic stem cell transplantation in neuromyelitis optica: a registry study of the EBMT Autoimmune Diseases Working PartyRaffaella Greco, Attilio Bondanza, Maria Carolina Oliveira, et al.
Pageof 45

Showing results (231-240 of 443) with videos related to

Sort By:
Pageof 45
Bone Marrow Transplantation|May 11, 2020
Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remissionRoni Shouval, Myriam Labopin, David Bomze, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantationArnon Nagler, Vanderson Rocha, Myriam Labopin, et al.
Bone Marrow Transplantation|September 29, 2019
Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working PartyAbdul Hamid Bazarbachi, Rama Al Hamed, Myriam Labopin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2020
Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent YearsAli Bazarbachi, Christoph Schmid, Myriam Labopin, et al.
Bone Marrow Transplantation|October 6, 2020
Comparable outcomes of haploidentical transplant with TBF conditioning versus matched unrelated donor with fludarabine/busulfan conditioning for acute myeloid leukemiaAli Bazarbachi, Myriam Labopin, Didier Blaise, et al.
American Journal of Hematology|July 31, 2018
Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remissionFrancesca Lorentino, Myriam Labopin, Massimo Bernardi, et al.
Leukemia|July 28, 2018
European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantationNicole Engel, Alicia Rovo, Manuela Badoglio, et al.
Blood|June 12, 2004
Hematopoietic stem cell transplantation for de novo acute megakaryocytic leukemia in first complete remission: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)Laurent Garderet, Myriam Labopin, Norbert-Claude Gorin, et al.
American Journal of Hematology|March 26, 2018
Cyclophosphamide versus etoposide in combination with total body irradiation as conditioning regimen for adult patients with Ph-negative acute lymphoblastic leukemia undergoing allogeneic stem cell transplant: On behalf of the ALWP of the European Society for Blood and Marrow TransplantationAnna Czyz, Myriam Labopin, Sebastian Giebel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 1, 2014
Autologous hematopoietic stem cell transplantation in neuromyelitis optica: a registry study of the EBMT Autoimmune Diseases Working PartyRaffaella Greco, Attilio Bondanza, Maria Carolina Oliveira, et al.
Pageof 45